Outlook Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $40k | 101k | 0.39 |
| 2023-09-30 | $22k | 101k | 0.22 |
| 2023-06-30 | $210k | 121k | 1.74 |
| 2023-03-31 | $0 | 119k | 0.00 |
| 2022-12-31 | $72k | 67k | 1.07 |
| 2022-06-30 | $0 | 63k | 0.00 |
| 2022-03-31 | $95k | 54k | 1.78 |
| 2021-12-31 | $47k | 35k | 1.37 |